Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker
Authors
- Roi Gat
- Ariel Israel (ORCID: https://orcid.org/0000-0003-4389-8896)
- Yakir Moshe
- Eugene Merzon
- Howard S. Oster (ORCID: https://orcid.org/0000-0003-1936-4675)
- Moshe Mittelman
- Itamar Raz
Institutions
- Tel Aviv Sourasky Medical Center (IL)
- Hadassah Medical Center (IL)
- Ariel University (IL)
- Clalit Health Services (IL)